1. To understand the correlation between deranged U+Es and pain management in patients, identifying key indicators to monitor pain levels and kidney function simultaneously. 2. To identify and determine the appropriate pain management strategies for patients with deranged U+Es, including considerations for non-pharmacological options if necessary. 3. To explore the different types of medications used in pain management for patients with deranged U+Es and analyze their potential impact on kidney function. 4. To learn how to effectively communicate and educate patients and their families about pain management strategies, taking into consideration their fears and concerns about potential kidney damage. 5. To discuss and analyze various case studies of patients with deranged U+Es, challenging attendees to decide on the appropriate pain management strategy and discussing the outcomes and implications in terms of patient care and treatment.